Earlier, in January 2025, the FDA released a companion piece of draft guidance titled “Considerations for the Use of ...

Despite heavy investments to acquire talented data scientists and take advantage of the analytics boom, many companies have been disappointed in the results. The problem is that those scientists ...

The latest advancements in these specifications and their potential to change vision and imaging technologies.

UiPath Inc. research and ratings by Barron's. View PATH revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.